EUVIMEDEUVIMED entdecken
Crossref

Macrocyclic 1,2-Hydroxypyridinone-Based Chelators as Potential Ligands for Thorium-227 and Zirconium-89 Radiopharmaceuticals

Joshua J Woods iD, Alexia G Cosby, Jennifer N Wacker, Luis M Aguirre Quintana, Appie Peterson, Stefan G Minasian iD, Rebecca J Abergel iD

Inorganic Chemistry · 2023

DOI: 10.1021/acs.inorgchem.3c02164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inorganic Chemistry, 2023. Verfasst von Joshua J Woods und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States. Hauptthemen laut MEDLINE: Chelating Agents, Radiopharmaceuticals. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 105 Literaturangaben. Gefördert von: Basic Energy Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thorium-227 (227Th) is an α-emitting radionuclide that has shown preclinical and clinical promise for use in targeted α-therapy (TAT), a type of molecular radiopharmaceutical treatment that harnesses high energy α particles to eradicate cancerous lesions. Despite these initial successes, there still exists a need for bifunctional chelators that can stably bind thorium in vivo. Toward this goal, we have prepared two macrocyclic chelators bearing 1,2-hydroxypyridinone groups. Both chelators can be synthesized in less than six steps from readily available starting materials, which is an advantage over currently available platforms. The complex formation constants (log βmlh) of these ligands with Zr4+ and Th4+, measured by spectrophotometric titrations, are greater than 34 for both chelators, indicating the formation of exceedingly stable complexes. Radiolabeling studies were performed to show that these ligands can bind [227Th]Th4+ at concentrations as low as 10-6 M, and serum stability experiments demonstrate the high kinetic stability of the formed complexes under biological conditions. Identical experiments with zirconium-89 (89Zr), a positron-emitting radioisotope used for positron emission tomography (PET) imaging, demonstrate that these chelators can also effectively bind Zr4+ with high thermodynamic and kinetic stability. Collectively, the data reported herein highlight the suitability of these ligands for use in 89Zr/227Th paired radioimmunotheranostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chelating AgentsRadiopharmaceuticalsThoriumRadioisotopesZirconiumPositron-Emission TomographyLigandsPyridones

Substanzen

Chelating AgentsRadiopharmaceuticalsThoriumRadioisotopesZirconiumLigandsZirconium-891,2-hydroxypyridinonePyridonesThorium-227

Autor:innen und Institutionen

  • Chemical Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States.
  • Nuclear Engineering, University of California Berkeley, Berkeley, California 94720, United States.

ORCID-Profile: Joshua J Woods, Stefan G Minasian, Rebecca J Abergel

Förderung

  • Basic Energy Sciences

Zitieren

APA

Woods, J. J., Cosby, A. G., Wacker, J. N., Aguirre Quintana, L. M., Peterson, A., Minasian, S. G., & Abergel, R. J. (2023). Macrocyclic 1,2-Hydroxypyridinone-Based Chelators as Potential Ligands for Thorium-227 and Zirconium-89 Radiopharmaceuticals. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.3c02164

Vancouver

Woods JJ, Cosby AG, Wacker JN, Aguirre Quintana LM, Peterson A, Minasian SG, et al. Macrocyclic 1,2-Hydroxypyridinone-Based Chelators as Potential Ligands for Thorium-227 and Zirconium-89 Radiopharmaceuticals. Inorganic Chemistry. 2023. doi:10.1021/acs.inorgchem.3c02164

BibTeX
@article{Woods2023,
  author = {Woods, Joshua J and Cosby, Alexia G and Wacker, Jennifer N and Aguirre Quintana, Luis M and Peterson, Appie and Minasian, Stefan G and Abergel, Rebecca J},
  title = {Macrocyclic 1,2-Hydroxypyridinone-Based Chelators as Potential Ligands for Thorium-227 and Zirconium-89 Radiopharmaceuticals},
  journal = {Inorganic Chemistry},
  year = {2023},
  doi = {10.1021/acs.inorgchem.3c02164}
}
Kostenlos starten →